A detailed history of Steward Partners Investment Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 181,470 shares of NVO stock, worth $19.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
181,470
Previous 189,458 4.22%
Holding current value
$19.1 Million
Previous $27 Million 20.1%
% of portfolio
0.2%
Previous 0.29%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $951,131 - $1.16 Million
-7,988 Reduced 4.22%
181,470 $21.6 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $938,976 - $1.12 Million
7,652 Added 4.21%
189,458 $27 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $2.7 Million - $3.59 Million
26,409 Added 16.99%
181,806 $23.3 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $1.65 Million - $1.99 Million
18,842 Added 13.8%
155,397 $16.1 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $7.17 Million - $15.7 Million
78,881 Added 136.77%
136,555 $12.4 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $57,400 - $63,535
-368 Reduced 0.63%
57,674 $9.33 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $1.01 Million - $1.22 Million
7,651 Added 15.18%
58,042 $9.24 Million
Q4 2022

Feb 15, 2023

BUY
$102.55 - $135.33 $2.22 Million - $2.93 Million
21,685 Added 75.54%
50,391 $6.82 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $548,241 - $672,815
5,754 Added 25.07%
28,706 $2.86 Million
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $978,508 - $1.15 Million
9,478 Added 70.34%
22,952 $2.56 Million
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $22,437 - $27,122
-241 Reduced 1.76%
13,474 $1.5 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $458,402 - $559,759
-4,781 Reduced 25.85%
13,715 $1.54 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $104,174 - $131,569
1,234 Added 7.15%
18,496 $1.78 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $61,773 - $77,385
-913 Reduced 5.02%
17,262 $1.45 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $22,532 - $25,475
336 Added 1.88%
18,175 $1.23 Million
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $28,431 - $32,841
-445 Reduced 2.43%
17,839 $1.25 Million
Q3 2020

Oct 30, 2020

SELL
$63.69 - $70.22 $186,293 - $205,393
-2,925 Reduced 13.79%
18,284 $1.27 Million
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $250,551 - $290,783
4,280 Added 25.28%
21,209 $1.39 Million
Q1 2020

Apr 29, 2020

BUY
$49.46 - $64.78 $296 - $388
6 Added 0.04%
16,929 $1.02 Million
Q4 2019

Jan 17, 2020

SELL
$49.86 - $58.26 $2,243 - $2,621
-45 Reduced 0.27%
16,923 $979,000
Q3 2019

Oct 30, 2019

BUY
$47.54 - $53.43 $11,599 - $13,036
244 Added 1.46%
16,968 $877,000
Q2 2019

Jul 25, 2019

BUY
$46.79 - $52.47 $4,725 - $5,299
101 Added 0.61%
16,724 $853,000
Q1 2019

Apr 30, 2019

BUY
$46.36 - $52.63 $22,345 - $25,367
482 Added 2.99%
16,623 $869,000
Q4 2018

Jan 15, 2019

BUY
$41.54 - $47.25 $6,978 - $7,938
168 Added 1.05%
16,141 $743,000
Q3 2018

Oct 23, 2018

SELL
$46.76 - $51.24 $4,956 - $5,431
-106 Reduced 0.66%
15,973 $753,000
Q2 2018

Jul 20, 2018

SELL
$44.29 - $50.42 $11,293 - $12,857
-255 Reduced 1.56%
16,079 $742,000
Q1 2018

Apr 20, 2018

BUY
$48.49 - $58.14 $3,927 - $4,709
81 Added 0.5%
16,334 $804,000
Q4 2017

Jan 19, 2018

BUY
$47.53 - $53.73 $11,074 - $12,519
233 Added 1.45%
16,253 $872,000
Q3 2017

Nov 22, 2017

SELL
$41.15 - $49.22 $20,328 - $24,314
-494 Reduced 2.99%
16,020 $771,000
Q2 2017

Nov 22, 2017

BUY
N/A
87 Added 0.53%
16,514 $708,000
Q1 2017

Nov 22, 2017

BUY
N/A
15,217 Added 1257.6%
16,427 $563,000
Q4 2016

Nov 22, 2017

BUY
N/A
1,210
1,210 $43,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.